BMC GenomicsGenomicsPeer-reviewed journal article
A Genome-wide Survey of Mutations in the Jurkat Cell Line
Louis GioiaiD, Azeem Siddique, Steven Robert HeadiD, Daniel R. Salomon, Andrew I. SuiD
- Citations
- 105
- FWCI
- 2.56
- Field percentile
- top 9%
Abstract
The Jurkat cell line has an extensive history as a model of T cell signaling. But at the turn of the 21st century, some irregularities were observed in Jurkats expression of central regulators of T cell receptor signaling, which raised doubts about how closely the cell line paralleled normal human T cells. While numerous expression deficiencies have been described in Jurkat, genetic explanations have only been provided for a handful of defects. Here, we report a comprehensive catolog of genomic variation in the Jurkat cell line based on whole-genome sequencing. With this list of all detectable, non-reference sequences, we prioritize potentially damaging mutations by mining public databases for functional effects. We confirm the majority of documented mutations in Jurkat and propose links from detrimental gene variants to observed expression abnormalities in the cell line. This work ties together decades of molecular experiments and serves as a resource that will streamline both the interpretation of past research and the design of future Jurkat studies.
- organism: human
- assay: whole-genome sequencing
- research focus: variant calling
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Base editing screens map mutations affecting IFNγ signalling in cancer
M. A. Coelho, E. Karakoc, … M. J. Garnett·bioRxiv·Mar 29, 2022
- Knockout and re-expression system for mutant analysis in primary mouse T cells
Vasileios Morfos, Meredith C. Frie, … Joanna Brzostek·bioRxiv·Aug 28, 2026
- A comprehensive atlas of somatic mutation rates and mutational signatures in normal human cells
My H. Pham, Luke M. R. Harvey, … Michael R. Stratton·bioRxiv·Aug 29, 2026
- STAT5B leukemic mutations, altering SH2 tyrosine 665, have opposing impacts on immune gene programs
Hye‐Kyung Lee, Jichun Chen, … Lothar G. Hennighausen·Life Science AlliancePeer-reviewed·Apr 14, 2025
- Mutational impact and signature of ionizing radiation
Jeonghwan Youk, Hyun Woo Kwon, … Young Seok Ju·bioRxiv·Jan 12, 2021
- Ruxolitinib partially reverses functional NK cell deficiency in patients with STAT1 gain-of-function mutations
A. Vargas Hernandez, E. M. Mace, … L. R. Forbes·bioRxiv·Jun 28, 2017